The prevalence and prognostic value of BRAF mutation in thyroid cancer (Q46200580)

20 December 2017

title

The prevalence and prognostic value of BRAF mutation in thyroid cancer (English)

1 reference

20 December 2017

author

Jürgen Bauer

3

1 reference

20 December 2017

Boris C. Bastian

8

1 reference

20 December 2017

Electron Kebebew

1

Electron Kebebew

1 reference

20 December 2017

Quan-Yang Duh

6

Quan-Yang Duh

1 reference

20 December 2017

Orlo Clark

5

Orlo H Clark

1 reference

20 December 2017

Julie Weng

2

Julie Weng

1 reference

20 December 2017

Daniel Shibru

7

Daniel Shibru

1 reference

20 December 2017

author name string

Gustavo Ranvier

4

1 reference

20 December 2017

Ann Griffin

9

1 reference

20 December 2017

language of work or name

English

0 references

publication date

1 September 2007

1 reference

20 December 2017

published in

Annals of Surgery

1 reference

20 December 2017

volume

246

1 reference

20 December 2017

issue

3

1 reference

20 December 2017

page(s)

466-70; discussion 470-1

1 reference

20 December 2017

Lymphatic mapping establishes the role of BRAF gene mutation in papillary thyroid carcinoma.

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Analysis of differential BRAF(V600E) mutational status in multifocal papillary thyroid carcinoma: evidence of independent clonal origin in distinct tumor foci.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Influence of the BRAF V600E mutation on expression of vascular endothelial growth factor in papillary thyroid cancer.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Correlation between B-RAFV600E mutation and clinico-pathologic parameters in papillary thyroid carcinoma: data from a multicentric Italian study and review of the literature.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

No correlation between BRAFV600E mutation and clinicopathological features of papillary thyroid carcinomas in Taiwan.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

BRAF mutation in thyroid cancer

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Independent clonal origins of distinct tumor foci in multifocal papillary thyroid carcinoma.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

The BRAFT1796A transversion is a prevalent mutational event in human thyroid microcarcinoma.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

BRAF mutations in an Italian cohort of thyroid cancers.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Annual report to the nation on the status of cancer, 1975-2001, with a special feature regarding survival

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

BRAF mutations in anaplastic thyroid carcinoma: implications for tumor origin, diagnosis and treatment

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

BRAF(V599E) mutation is the leading genetic event in adult sporadic papillary thyroid carcinomas

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Clinical implication of hot spot BRAF mutation, V599E, in papillary thyroid cancers

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

High prevalence of BRAF gene mutation in papillary thyroid carcinomas and thyroid tumor cell lines.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid.

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Differentiated thyroid cancer: "complete" rational approach

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma

29 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

The BRAFV600E mutation is not associated with poor prognostic factors in Korean patients with conventional papillary thyroid microcarcinoma

1 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1959359

Type and prevalence of BRAF mutations are closely associated with papillary thyroid carcinoma histotype and patients’ age but not with tumour aggressiveness

1 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17717450

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Increasing incidence of thyroid cancer in the United States, 1973-2002

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17717450

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1097/SLA.0B013E318148563D

1 reference

20 December 2017

0 references

1 reference

20 December 2017